These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Hicks K, Peng D, Gajewski JL. Bone Marrow Transplant; 2002 Dec; 30(12):975-8. PubMed ID: 12476294 [Abstract] [Full Text] [Related]
7. [Diffuse alveolar hemorrhage after allogeneic bone marrow transplantation]. Ishida T, Arita M, Fujimori N. Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):369-73. PubMed ID: 8778482 [Abstract] [Full Text] [Related]
8. Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Majhail NS, Parks K, Defor TE, Weisdorf DJ. Bone Marrow Transplant; 2006 Dec; 38(11):765-8. PubMed ID: 17028622 [Abstract] [Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
10. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Kaya Z, Weiner DJ, Yilmaz D, Rowan J, Goyal RK. Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213 [Abstract] [Full Text] [Related]
11. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D. Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742 [Abstract] [Full Text] [Related]
12. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT? Ancín I, Ferrá C, Gallardo D, Peris J, Berlanga J, Gonzalez JR, Virgili N, Grañena A. Bone Marrow Transplant; 2001 Jul; 28(1):39-45. PubMed ID: 11498742 [Abstract] [Full Text] [Related]
13. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
14. [Diffuse alveolar hemorrhage after allogeneic bone marrow transplantation]. Mori M, Arai T, Kijima T, Sakuma-Mochizuki J, Abe K, Kumagai T, Yoshida M, Ueno K, Hosoe S, Ogawa H, Hayashi S. Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):928-33. PubMed ID: 18217317 [Abstract] [Full Text] [Related]
15. Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients. Cheng G, Smith MA, Phelan R, Brazauskas R, Strom J, Ahn KW, Hamilton B, Peterson A, Savani B, Schoemans H, Schoettler M, Sorror M, Higham C, Kharbanda S, Dvorak CC, Zinter MS. Transplant Cell Ther; 2024 Oct; 30(10):1017.e1-1017.e12. PubMed ID: 39089527 [Abstract] [Full Text] [Related]
16. Allogeneic BMT in patients above 45 years of age: a single center experience. Lysák D, Koza V, Jindra P, Vozobulová V, Schutzová M, Fiser J, Cerná K, Karas M, Skopek P, Svojgrová M, Vokurka S. Bone Marrow Transplant; 2001 Apr; 27(7):723-6. PubMed ID: 11360112 [Abstract] [Full Text] [Related]
17. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies. Valcárcel D, Martino R, Sureda A, Canals C, Altés A, Briones J, Sanz MA, Parody R, Constans M, Villela SL, Brunet S, Sierra J. Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906 [Abstract] [Full Text] [Related]
18. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft. di Grazia C, Raiola AM, Van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Dominietto A, Mordini N, Bruno B, Frassoni F, Bacigalupo A. Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375 [Abstract] [Full Text] [Related]
19. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J. Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [Abstract] [Full Text] [Related]
20. Long-term outcome after allogeneic bone marrow transplantation for hematological malignancies with non-remission status. Results of a single-center study of 24 patients. Tabata M, Satake A, Okura N, Yamazaki Y, Toda A, Nishioka K, Tanaka H, Chin M, Itsukuma T, Yamaguchi M, Misawa M, Kai S, Hara H. Ann Hematol; 2002 Oct; 81(10):582-7. PubMed ID: 12424540 [Abstract] [Full Text] [Related] Page: [Next] [New Search]